Demographics All patients (n=1114)
Group wRM (n=265)
Group w/oRM (n=849)
p-value
Age, yrs
64.5 ± 18.4
63.3±17.9
64.2±18.3
0.74
Male, n (%)
638 (57.3)
149 (56.2)
489 (57.6)
0.69
CIED
ICD, n (%)
429 (38.5)
100 (37.7)
329 (38.8)
0.76
Single Chamber, n (%)
228 (20.5)
57 (21.5)
171 (20.1)
0.37
Dual Chamber, n (%)
177 (15.8)
34 (12.8)
143 (16.8)
0.09
S-ICD, n (%)
24 (2.2)
9 (3.4)
15 (1.8)
0.22
PM, n (%)
425 (38.1)
102 (38.5)
323 (38.0)
0.89
Single Chamber, n (%)
61 (5.5)
18 (6.8)
43 (5.1)
0.28
Dual Chamber, n (%)
364 (32.6)
84 (31.7)
280 (33.0)
0.28
ILR, n (%)
171 (15.4)
35 (13.2)
136 (16.0)
0.27
CRT, n (%)
89 (8.0)
19 (7.2)
70 (8.2)
0.57
Heart Disease
No, n (%)
101 (9.1)
25 (9.4)
76 (8.9)
0.81
Ischaemic HD, n (%)
451 (40.5)
95 (35.8)
356 (41.9)
0.08
Valvular HD, n (%)
116 (10.4)
24 (9.1)
92 (10.8)
0.41
Channelopathies, n (%)
12 (1.1)
2 (0.8)
10 (1.2)
1
Congenital HD, n (%)
7 (0.6)
1 (0.4)
6 (0.7)
1
Others, n (%)
22 (2)
5 (1.9)
17 (2.0)
0.92
NYHA
I, n (%)
278 (25.0)
63 (23.8)
215 (25.3)
0.61
II, n (%)
473 (42.5)
117 (44.2)
356 (41.9)
0.52
III, n (%)
330 (29.6)
78 (29.4)
252 (29.7)
0.92
IV, n (%)
33 (2.9)
7 (2.6)
26 (3.1)
0.73
LVEF [range]
46 ± 12 [20 – 60]
44 ± 11 [20 – 60]
45 ± 12 [20 – 60]
0.81
Comorbidities
Diabetes mellitus, n (%)
413 (37.1)
101 (38.1)
312 (36.7)
0.69
Chronic Obstructive Pulmonary Disease, n (%)
187 (16.8)
40 (15.1)
147 (17.3)
0.40
Hypertension, n (%)
601 (53.9)
146 (55.1)
455 (53.6)
0.67
Chronic Kidney Disease, n (%)
231 (20.7)
52 (19.6)
179 (21.1)
0.61